Article
Somatic mutation detection in human biomonitoring.
Pharmacology & toxicology - 1 Jun 1996
Olsen L S, Nielsen L R, Nexø B A, Wassermann K
Abstract excerpt
Somatic cell gene mutation arising in vivo may be considered to be a biomarker for genotoxicity. Assays detecting mutations of the haemoglobin and glycophorin A genes in red blood cells and of the hypoxanthine-guanine phosphoribosyltransferase and human leucocyte antigenes in T-lymphocytes are available in humans. This MiniReview describes these assays and their application to studies of individuals exposed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
